Literature DB >> 30328501

Thalamic and dentate nucleus abnormalities in the brain of children with Gaucher disease.

Giulia Perucca1, Bruno P Soares2, Serena Staglianò3, James Davison4, Anupam Chakrapani4, Felice D'Arco5.   

Abstract

Gaucher disease (GD) represents the most common lysosomal storage defect. It is classified into three phenotypes: type 1 non-neuronopathic, type 2 acute neuronopathic, and type 3 subacute/chronic neuronopathic. Although children affected by GD may present with a broad spectrum of neurological signs, brain magnetic resonance imaging (MRI) findings are usually normal or non-specific. We report three cases of GD with previously undescribed brain MRI changes mainly affecting the thalami and/or the dentate nuclei. We discuss the possible etiopathogenesis of these abnormalities. Correlation between brain MRI abnormalities, neurological symptoms, and treatment efficacy is still unclear.

Entities:  

Keywords:  Brain; Diffusion-weighted imaging; Gaucher disease; Lysosomal storage disorders; Magnetic resonance imaging

Mesh:

Year:  2018        PMID: 30328501     DOI: 10.1007/s00234-018-2116-z

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  10 in total

Review 1.  Diffusion-weighted imaging of acute excitotoxic brain injury.

Authors:  Toshio Moritani; Wendy R K Smoker; Yutaka Sato; Yuji Numaguchi; Per-Lennart A Westesson
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

2.  Type 1 and type 3 Gaucher disease in two siblings in a family: 2 unusual case reports.

Authors:  Dolanchampa Modak; Sasmit Roy; Uttam Nath; S K Guha
Journal:  J Clin Diagn Res       Date:  2015-02-01

3.  Brain white matter abnormalities in paediatric Gaucher Type I and Type III using diffusion tensor imaging.

Authors:  Elin Haf Davies; Kiran K Seunarine; Tina Banks; Chris A Clark; Ashok Vellodi
Journal:  J Inherit Metab Dis       Date:  2011-02-12       Impact factor: 4.982

4.  Persistent diffusion abnormalities in the brain stem of three children with mitochondrial diseases.

Authors:  Y Sakai; R Kira; H Torisu; K Ihara; T Yoshiura; T Hara
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

5.  Brain development in infantile-onset Pompe disease treated by enzyme replacement therapy.

Authors:  Yin-Hsiu Chien; Ni-Chung Lee; Shinn-Forng Peng; Wuh-Liang Hwu
Journal:  Pediatr Res       Date:  2006-07-20       Impact factor: 3.756

6.  Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3.

Authors:  U H Schueler; T Kolter; C R Kaneski; J K Blusztajn; M Herkenham; K Sandhoff; R O Brady
Journal:  Neurobiol Dis       Date:  2003-12       Impact factor: 5.996

7.  Neurological and brain MRS findings in patients with Gaucher disease type 1.

Authors:  Saadet Mercimek-Mahmutoglu; Stephan Gruber; Arndt Rolfs; Andreas Stadlbauer; Christian Woeber; Peter Kurnik; Till Voigtlaender; Ewald Moser; Sylvia Stoeckler-Ipsiroglu
Journal:  Mol Genet Metab       Date:  2007-06-08       Impact factor: 4.797

Review 8.  Gaucher Disease: Clinical, Biological and Therapeutic Aspects.

Authors:  Azza Dandana; Souhaira Ben Khelifa; Hinda Chahed; Abdelhédi Miled; Salima Ferchichi
Journal:  Pathobiology       Date:  2015-11-21       Impact factor: 4.342

9.  Proton MR Spectroscopy of the brain in children with neuronopathic Gaucher's disease.

Authors:  Ahmed Abdel Khalek Abdel Razek; Ahmed Abdalla; Nahed Abdel Gaber; Abeer Fathy; Ahmed Megahed; Tarek Barakat; Mona Abdel Latif Alsayed
Journal:  Eur Radiol       Date:  2013-06-20       Impact factor: 5.315

10.  Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits.

Authors:  Ying Sun; Benjamin Liou; Huimin Ran; Matthew R Skelton; Michael T Williams; Charles V Vorhees; Kazuyuki Kitatani; Yusuf A Hannun; David P Witte; You-Hai Xu; Gregory A Grabowski
Journal:  Hum Mol Genet       Date:  2010-01-04       Impact factor: 6.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.